Evaluation of Disease Burden in Parkinson’s Disease for Individuals Aged 60 and Older
Neuroepidemiology · 13.11.2026 · 60 (6) · 1014-1024
DOI: 10.1159/000549622 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuroepidemiology, online erschienen am 25.11.2025. Verfasst von Junjiao Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Public Health, Shanxi Medical University, Taiyuan, China. Hauptthemen laut MEDLINE: Parkinson Disease, Disability-Adjusted Life Years, Cost of Illness, Global Burden of Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanxi Province.
Abstract (Originalsprache)
Objective
The aim of the study to evaluate global trends in Parkinson’s disease (PD) burden (measured by disability-adjusted life years, DALYs) among individuals aged ≥60 years from 1990 to 2021, and project future trends to 2046.
Methods
Using Global Burden of Disease (GBD) 2021 data, we analyzed age-standardized DALY rates (ASDR) via Joinpoint regression. Age-Period-Cohort (APC) modeling disentangled age, period, and birth cohort effects. Decomposition analysis quantified contributions of population growth, aging, and epidemiological changes. Bayesian APC (BAPC) projected DALYs to 2046.
Results
Global PD DALYs increased from 2.55 million (95% uncertainty interval: 2.33–2.79) in 1990 to 6.80 million (6.04–7.49) in 2021. ASDR rose annually by 0.31% (average annual percent change = 0.31%, 95% CI: 0.29–0.33), with pronounced male predominance (male ASDR 2021: 861.9 vs. female: 498.9; male-to-female ratio: 1.73). The highest ASDR occurred in high-middle socio-demographic index (SDI) regions (683.7) and the lowest occurred in low SDI (612.9). APC analysis revealed disease risk peaked at ages 85–94 and increased with successive birth cohorts. Decomposition identified population growth as the primary driver of DALY increases (81.55% globally), exceeding contributions from aging (8.74%) and epidemiological shifts (9.71%). BAPC projections indicated rising absolute DALYs (+104% by 2046) but declining ASDR (607.3 by 2046), with widening gender disparities.
Conclusion
PD burden escalates globally due to demographic aging and population growth. Urgent international collaboration is needed for targeted interventions, particularly in high-burden regions and for older males.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Public Health, Shanxi Medical University, Taiyuan, China.
- The First Clinical Medical College, Shanxi Medical University, Taiyuan, China.
- Second Clinical Medical College, Nanchang University, Nanchang, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shanxi Province
Zitieren
APA
Liu, J., Tong, Y., Qu, X., Liu, Y., Liu, X., & Zheng, J. (2026). Evaluation of Disease Burden in Parkinson’s Disease for Individuals Aged 60 and Older. Neuroepidemiology, 60(6), 1014-1024. https://doi.org/10.1159/000549622
Vancouver
Liu J, Tong Y, Qu X, Liu Y, Liu X, Zheng J. Evaluation of Disease Burden in Parkinson’s Disease for Individuals Aged 60 and Older. Neuroepidemiology. 2026;60(6):1014-1024. doi:10.1159/000549622
BibTeX
@article{Liu2026,
author = {Liu, Junjiao and Tong, Yan and Qu, Xinyi and Liu, Yueyang and Liu, Xiaohan and Zheng, Jianzhong},
title = {Evaluation of Disease Burden in Parkinson’s Disease for Individuals Aged 60 and Older},
journal = {Neuroepidemiology},
year = {2026},
volume = {60},
number = {6},
pages = {1014--1024},
doi = {10.1159/000549622}
}
EUVIMED